2024-2029 Global Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database for the US, Europe and Japan: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for over 40 Transfusion/Immunohematology Tests

January 2025 | - | ID: 2800D2902EC0EN
Venture Planning Group

US$ 17,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This database from LeadingMarketResearch.com provides the 2024 supplier shares, the 2024-2029 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT
Geographic Regions
Europe
France
Germany
Italy
Japan
Spain
UK
US


More Publications